# Argatroban Plus R-tPA for Acute Ischemic Stroke

Study · id `cardio:ct-nct03740958` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03740958](<https://clinicaltrials.gov/study/NCT03740958>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03740958

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 808 participants.

## Technical summary

Registry record NCT03740958. Randomized; no masking; primary purpose treatment. Start 2018-12-21 (actual); primary completion 2022-01-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 808 participants (enrolled count; ClinicalTrials.gov record NCT03740958, source copy `cardio:ctgov-nct03740958-2022-02-22`, retrieved 2026-10-26)
- Started: 2018-12-21 (actual) (ClinicalTrials.gov record NCT03740958, source copy `cardio:ctgov-nct03740958-2022-02-22`, retrieved 2026-10-26)
- Primary completion: 2022-01-30 (actual) (ClinicalTrials.gov record NCT03740958, source copy `cardio:ctgov-nct03740958-2022-02-22`, retrieved 2026-10-26)
- Completion: 2022-01-30 (actual) (ClinicalTrials.gov record NCT03740958, source copy `cardio:ctgov-nct03740958-2022-02-22`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03740958, source copy `cardio:ctgov-nct03740958-2022-02-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03740958-2022-02-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Argatroban Plus R-tPA for Acute Ischemic Stroke
- Condition: Stroke
- Intervention (Drug): rt-PA
- Intervention (Drug): Argatroban
- Lead sponsor: General Hospital of Shenyang Military Region
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial (`cardio:pubmed-36757755`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Circadian Rhythm and Efficacy of Argatroban in Ischemic Stroke with Alteplase: A Post Hoc Analysis of the ARAIS Trial (`cardio:pubmed-41678142`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c952bbd0d98659c3e0d848b1bcf5f3a0e91c13e78ebd93502d6c844cd41c9bd5
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
